ArticleiScience2026

Bispecific antibodies targeting TL1A and IL-12/23p40 suppress pathogenic Th1/Th17 responses and ameliorate colitis in mice.

Xia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.